相关实验视频

Updated: Mar 18, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

修改的解剖学废除策略,以对位管支流

Kui He^1,2, Yifei Lu², Yuan Zhang²

¹Wenzhou Medical University, Zhejiang, China.

Pacing and clinical electrophysiology : PACE

|March 17, 2026

概括

马歇尔静脉中乙醇输液 (EI-VOM) 与部分切除相结合,在持久性心房动 (AF) 患者中有效地实现了 mitra isthmus (MI) 阻塞. 这一策略显示出高成功率和中期鼻节律稳定性.

科学领域:

心脏病学心脏病学
电子生理学电子生理学
医疗器械技术医疗器械技术

背景情况:

持久的 mitra 胸 (MI) 阻断在持续性心房动 (AF) 时至关重要,但具有挑战性.
马歇尔静脉中乙醇输注 (EI-VOM) 是一种辅助疗法,但最佳除程度尚不清楚.

研究的目的:

为了定义MI块后EI-VOM所需的最低内心脏切除程度.
为了评估EI-VOM的疗效和安全性,结合持续性AF的逐步切除.

主要方法:

对35名持续性AF患者进行首次切除的前性研究.
EI-VOM (11.10 ± 2.24 mL乙醇) 随后进行双边肺静脉隔离 (PVI),线性切除,并逐步进行MI切除.
主要终点:急性心脏病阻断,病变要求和6个月的鼻节律 (SR) 维持.

主要成果:

88.6%的患者获得了急性心脏病发作阻断,平均5.03±4.51内心病变.
在较小的左心房 (<45毫米) 需要较少的病变.
在90%的部分内心脏剥离病例中,EI-VOM促进了MI阻断;6个月的SR维持率为88.5%,没有重大并发症.

结论:

EI-VOM与部分内心脏切除进行MI阻塞的协同作用,特别是在非扩张的左心房.
建议在心房扩张的情况下进行辅助冠状动脉鼻切除.
该策略显示高中期有效性,但非解剖学因素可能会影响复发.

关键词:

马歇尔静脉中的乙醇输注.mitrale 胸移除胸移除持续的心房动持续的心房动

更多相关视频

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

相关概念视频

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Mitral Regurgitation III: Medical Management

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...